Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 15272416)

Published in J Infect Dis on July 16, 2004

Authors

Anne H Rowley1, Susan C Baker, Stanford T Shulman, Francesca L Garcia, Judith A Guzman-Cottrill, Pauline Chou, Masaru Terai, Tomisaku Kawasaki, Mitra B Kalelkar, Susan E Crawford

Author Affiliations

1: Departments of Pediatrics and Microbiology/Immunology, Feinberg School of Medicine, Children's Memorial Hospital, Northwestern University, Chicago, Illinois 60611, USA. a-rowley@northwestern.edu

Articles citing this

RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One (2008) 1.13

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12

Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med (2011) 1.08

Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther (2010) 1.08

Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One (2011) 1.08

Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol (2009) 1.07

Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05

Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis (2005) 0.97

Immune response in human cerebral cavernous malformations. Stroke (2009) 0.94

Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. ScientificWorldJournal (2012) 0.93

Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis (2010) 0.89

Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep (2010) 0.89

What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol (2007) 0.87

Kawasaki disease: basic and pathological findings. Clin Exp Nephrol (2012) 0.86

Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol (2015) 0.84

Kawasaki disease. Proc Jpn Acad Ser B Phys Biol Sci (2006) 0.80

Kawasaki disease in two sets of monozygotic twins: Is the etiology genetic or environmental? Pak J Med Sci (2013) 0.79

Neonatal Kawasaki disease: case report and data from nationwide survey in Japan. Eur J Pediatr (2014) 0.77

Human coronavirus-NL63 infection is not associated with acute Kawasaki disease. Adv Exp Med Biol (2006) 0.75

Articles by these authors

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 11.64

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation (2005) 10.98

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics (2004) 8.10

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev (2003) 5.91

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98

What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis (2008) 4.44

RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol (2002) 3.69

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol (2011) 2.85

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77

Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2009) 2.64

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol (2005) 2.49

Baylisascariasis. Clin Microbiol Rev (2005) 2.29

Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A (2006) 2.28

Infliximab treatment for refractory Kawasaki syndrome. J Pediatr (2005) 2.21

Urethroplasty with abdominal skin grafts for long segment urethral strictures. J Urol (2010) 2.19

Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19

Integrating abundance and functional traits reveals new global hotspots of fish diversity. Nature (2013) 2.13

Kawasaki disease - an Indian perspective. Indian Pediatr (2009) 2.13

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem (2007) 2.07

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc (2007) 1.98

The Great Migration of 2015. Pediatr Ann (2015) 1.98

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol (2004) 1.97

Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med (2003) 1.97

Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95

Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol (2005) 1.81

Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics (2009) 1.76

Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol (2010) 1.64

Unique features of infective endocarditis in childhood. Circulation (2002) 1.61

Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology (2005) 1.59

A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58

Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med (2003) 1.56

Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol (2008) 1.56

Dynamic epidemiology of group A streptococcal serotypes. Lancet (2002) 1.50

Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2. J Virol (2003) 1.47

Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease. Circ J (2011) 1.47

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res (2002) 1.47

Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45

Even skeptics must be aware of data on alternative therapies. Pediatr Ann (2004) 1.45

Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45

Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev (2004) 1.44

Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol (2007) 1.41

Mortality and risk factors for late deaths in tetralogy of Fallot: the Japanese Nationwide Multicentric Survey. Cardiol Young (2002) 1.41

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A (2008) 1.39

Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J Virol (2007) 1.39

Preventing injuries (all kinds). Pediatr Ann (2010) 1.39

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Int J Cancer (2002) 1.37

Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab (2003) 1.36

Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician (2006) 1.36

Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol Cell Biol (2006) 1.33

Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology (2007) 1.31

A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet (2006) 1.30

Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis (2005) 1.29

Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS One (2012) 1.28

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant (2011) 1.28

A mouse model for human osteogenesis imperfecta type VI. J Bone Miner Res (2013) 1.27

Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol (2002) 1.21

Unique features of infective endocarditis in childhood. Pediatrics (2002) 1.20

Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet (2010) 1.20

Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res (2007) 1.20

Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J Virol (2008) 1.19

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol (2005) 1.18

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc (2008) 1.17

Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res (2004) 1.16

Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem (2002) 1.15

Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis (2004) 1.15

New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr (2007) 1.14

Neural larva migrans caused by the raccoon roundworm Baylisascaris procyonis. Pediatr Infect Dis J (2002) 1.14

Eye findings of diffuse unilateral subacute neuroretinitis and multiple choroidal infiltrates associated with neural larva migrans due to Bbaylisascaris procyonis. Am J Ophthalmol (2003) 1.13

Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. Virology (2008) 1.13

Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors. J Med Chem (2005) 1.13

The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest (2011) 1.13

RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One (2008) 1.13

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12

Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008. Clin Infect Dis (2009) 1.12

Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol (2003) 1.11

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr (2002) 1.09

Investigation of bacterial pathogens on 70 frequently used environmental surfaces in a large urban U.S. university. J Environ Health (2009) 1.08

Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther (2010) 1.08

Distinctive clinical features of human bocavirus in children younger than 2 years. Eur J Pediatr (2010) 1.08

Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates. Clin Infect Dis (2009) 1.05

Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol (2006) 1.04